HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302

An antibody-targeted lipidic nano-carrier containing the antineoplastic anthracycline antibiotic doxorubicin encapsulated within liposomes, and conjugated to a monoclonal antibody against the human epidermal growth factor receptor 2 (HER2), with potential antitumor activity. Upon administration of HER2-targeted liposomal doxorubicin hydrochloride MM-302, the immunoliposome allows for specific delivery of doxorubicin to tumors overexpressing the HER2 receptor. Once inside the HER2-expressing tumor cells, doxorubicin intercalates into DNA and interferes with topoisomerase II activity, thereby inhibiting DNA replication and RNA synthesis. Compared to doxorubicin alone or liposomal doxorubicin, targeted liposomal delivery of doxorubicin improves efficacy while lowering the toxicity profile. HER2, a tyrosine kinase receptor, is overexpressed in many cancer cell types. (NCI Thesaurus)

YOU MAY ALSO LIKE

HER2 test

A laboratory test that measures the amount of HER2 protein on cancer cells or how many copies of the HER2 gene are…

HER2 Positive Breast Carcinoma

A biologic subset of breast carcinoma with a unique molecular signature or expression profile, defined by high expression of HER2, GRB7, and…

HER2 positive

Describes cancer cells that have too much of a protein called HER2 on their surface. In normal cells, HER2 helps to control…

HER2 negative

Describes cancer cells that do not have a large amount of a protein called HER2 on their surface. In normal cells, HER2…

HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901

A cancer vaccine based on virus-like replicon particles (VRP) packaged with an alphaviral vector encoding the extracellular domain (ECD) and transmembrane (TM)…

HER2 Antigen Measurement

The determination of the amount of HER2 antigen, including peptides, epitopes, and receptor, present in a sample.